MHRA approves Pfizer-BioNTech’s Comirnaty JN.1 vaccine
The approval encompasses four variations of the Comirnaty JN.1 vaccine, following the International Recognition Procedure.
The approval encompasses four variations of the Comirnaty JN.1 vaccine, following the International Recognition Procedure.